• -Issues relating to corporate tax reform -H.R.523 Protect Medical Innovation Act of 2013 -S. 232 Medical Device Access and Innovation Protection Act -H.CON.RES.96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024. -S. 2260, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders) -H.R.5771 -- Tax Increase Prevention Act of 2014 -H.J. Res 124, Continuing Appropriations Resolution (Export-Import Bank Reauthorization)
• -Issues relating to corporate tax reform -H.R.523 Protect Medical Innovation Act of 2013 -S. 232 Medical Device Access and Innovation Protection Act -H.CON.RES.96, Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024. -S. 2260, Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act (tax extenders) -H.R.5771, Tax Increase Prevention Act of 2014 -H.J. Res 124, Continuing Appropriations Resolution (Export-Import Bank Reauthorization)

Duration: July 1, 2009 to December 31, 2014

General Issues: Taxation/Internal Revenue Code, Budget/Appropriations, Financial Institutions/Investments/Securities, Defense

Spending: about $3,240,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2009: U.S. Senate, House of Representatives, Senate, House of Representatives